APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,563,708 | -56.5% | 2,777 | -99.0% | 1.27% | -67.2% |
| Q2 2023 | $24,305,480 | +268.5% | 266,800 | +166.8% | 3.87% | +158.6% |
| Q1 2023 | $6,595,999 | -11.7% | 100,000 | -39.4% | 1.50% | +10.0% |
| Q2 2022 | $7,466,000 | -16.1% | 165,100 | -5.7% | 1.36% | +16.3% |
| Q1 2022 | $8,896,000 | -5.9% | 175,100 | -12.4% | 1.17% | -16.9% |
| Q4 2021 | $9,455,000 | -69.0% | 200,000 | -78.4% | 1.41% | -34.5% |
| Q3 2021 | $30,520,000 | -19.5% | 925,945 | +54.3% | 2.15% | -29.9% |
| Q2 2021 | $37,920,000 | +6611.5% | 600,000 | +3104.1% | 3.07% | +7378.0% |
| Q3 2020 | $565,000 | +718.8% | 18,726 | +780.8% | 0.04% | +720.0% |
| Q2 2020 | $69,000 | -95.1% | 2,126 | -95.9% | 0.01% | -95.2% |
| Q1 2020 | $1,396,000 | -91.4% | 52,126 | -90.1% | 0.10% | -96.0% |
| Q4 2019 | $16,145,000 | – | 527,253 | – | 2.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |